Traditional Chinese medicines (TCM) are a rich source of potential leads for drug development. However, there are fundamental differences between traditional Chinese medical concepts and modern pharmacology, which greatly hinder the modern development of TCM. To address this challenge, new techniques associated with genomics, transcriptomics, proteomics, metabolomics and bioinformatics have been used to dissect the pharmacological mechanisms of TCM. This review article provides an overview of the current research in this area, and illustrates the potential of omic and bioinformatic methods in TCM-based drug discovery.
Introduction
Finding new drugs to treat various human diseases is a major driving force for life sciences. However, despite the rapidly growing investment in the past decade, the number of new chemical entities approved per year has declined gradually [1] . Therefore, how to improve drug-discovery efficiency is a major challenge to the pharmaceutical industry and life sciences. In the field of drug discovery, historical experience is always helpful, and it was stated by the late Nobel laureate Sir James Black that "the most fruitful basis for the discovery of a new drug is to start with an old drug" [2] . Indeed, the historical experience involved in traditional medicines has attracted considerable attention from the modern pharmaceutical industry [3] [4] [5] .
Traditional Chinese medicines (TCM) represent one of the most ancient therapeutic systems and have become a research focus in recent years. After over 5000 years of development, TCM are still very popular in China and are becoming to be accepted by Western countries [6] . By the continuing efforts of numerous medicinal chemists, a large number of active components have been identified from TCM, which have been recognized as a rich source of new drugs [7] .
Despite the great successes attained in TCM research in the past century, there are fundamental differences between traditional Chinese medical concepts and modern pharmacology, which greatly hinder the modern development of TCM. The past decade has witnessed rapid progresses in omics technologies (e.g., genomics, transcriptomics, proteomics and metabolomics), and the accompanied development of bioinformatics. In this review, we summarize some powerful omic and bioinformatic approaches used in elucidating the pharmacological mechanisms of TCM, which are expected to assist the TCM-based drug discovery (Figure 1 ).
Dissecting TCM by Omics
With the birth of next generation sequencing (NGS), genomics has gained great impetus in recent years. The facile determination of genomes and gene expression levels has contributed greatly to biomedical sciences. For instance, according to the records in the National Center for Biotechnology Information (NCBI), there are many plant genomes sequenced or under sequencing, some of which are TCM herbs ( Table 1 ). The herbal genome information is greatly helpful to elucidate the structures and functions of TCM components, which will provide new insights into the mechanisms of TCM formulae [8, 9] .
DNA microarray has the power to characterize systematically the gene expression profiles of different kinds of cells or tissues. Therefore, microarray can be used to identify the gene expression alterations in response to pathogens or other environmental stimulations [10] . In recent years, there has been an increasing interest in using DNA microarray to study the action mechanisms of TCM [11, 12] .
San-Huang-Xie-Xin-Tang (SHXXT), consisting of Rheum palmatum L., Scutellaria baicalensis Georgi and Coptis chinensis Franch., has been used in China for over 1,800 years to treat gastritis, gastric bleeding and peptic ulcers [13] . To explore the therapeutic mechanisms of the formula, microarray was applied to analyze the gene expression profiles of HepG2 cells treated with SHXXT. The results indicated that SHXXT exerts an antiproliferation effect via regulating p53 and DNA damage signaling pathways. Moreover, the gene expression profile after SHXXT treatment is similar to that of Coptis chinensis Franch. treatment, implying that this plant is the major agent of SHXXT [14] .
The Connectivity Map (cMap) is a collection of microarray expression data from cultured human cells treated with bioactive small molecules [15] . Comparing the expression profiles of TCMregulated genes with those recorded in cMap is very helpful to uncover the working mechanisms of TCM agents and formulae. Si-Wu-Tang (SWT), consisting of Angelica sinensis (Oliv.) Diels, Rehmannia glutinosa (Gaertn.) Libosch. ex Fisch. & C. A. Mey., Paeonia lactiflora Pall. and Ligusticum chuanxiong hort. ex S. H. Qiu et al., has been used in China and Japan for over 1,000 years for the relief of perimenopausal syndrome, menstrual discomfort and other estrogen-related diseases. The gene expression profiles after SWT treatment display a significant match with estradioltreated MCF-7 cells in the cMap database, which is consistent with SWT's phytoestrogenic effect and related functions on gynecological diseases [12] . To reveal the pharmacological mechanisms of the top 15 most used Chinese herbal medicines in the National Health Insurance Database of Taiwan Chinese herbal medicine, microarray was used to analyze their transcriptomic profiles [11] . The mice treated with 15 formulae for 7 consecutive days showed a similarity in cMap with drugs exhibiting anti-cancer, anti-inflammatory and antioxidative effects [11] . In brief, genomic and transcriptomic studies provide deep insights into the therapeutic mechanisms of TCM. However, since the expression levels of genes and proteins are not necessarily always highly correlated, a more comprehensive elucidation of TCM action mechanisms will have to resort to proteomics.
Proteomics technology is based on the systemic identification, quantification and post-transcriptional modification of proteins/peptides and their interactions by mass spectrometry coupled with various protein isolation methods [16] . The systemic protein maps could provide new clues to clarifying the cellular and molecular mechanisms of human physiology and diseases [12] . The significant potential of proteomics application in TCM is to perform large-scale screening for the protein expressions, which is beneficial to the discovery of new bioactive components, pharmacological effects and the action mechanisms of TCM.
Tianqi Jiangtang Capsule (TJC), composed of ten herbal components: Trichosanthes kirilowii Maxim., Panax ginseng C. A. Mey., Coptis chinensis Franch., Astragalus membranaceus Moench, Ligustrum lucidum W. T. Aiton, Dendrobium nobile Lindl., Lycium chinense Mill., Cornus officinalis Siebold & Zucc., Eclipta prostrata (L.) L. and Rhus chinensis Mill., is used as an anti-diabetic formula. Serum proteomic study in a rat model of type 2 diabetes mellitus (T2DM) displayed that apolipoprotein E, apolipoprotein A-I and Ig gamma-2A chain C region were Dissecting Traditional Chinese Medicines by omics and bioinformatics Natural Product Communications Vol. 9 (9) 2014 1393 down-regulated, while transthyretin, haptoglobin, serum amyloid P-componen and prothrombin were up-regulated. Interestingly, the majority of the differential serum proteins in T2DM were restored to those of healthy rats after TJC treatment. It was thus concluded that a potential action mechanism of TJC on T2DM involves regulating the expression of these serum proteins [17] .
Paeonia veitchii Lynch, used as a natural medicine in China for a long period, can reduce fever, cool blood, eliminate stasis, activate blood circulation and relieve pain [18] . Xie et al. explored the effects of P. veitchii on the serum proteome of rats suffering from noxious heat with blood stasis syndrome. After being treated with P. veitchii, the expression of serum proteins 1, 2, 3, 4 and 9 significantly decreased, with the serum protein 16 times increased, which makes the expressions of these serum proteins return to their normal level. These results strongly suggest that the therapeutic effects of P. veitchii on noxious heat with blood stasis syndrome are through the regulation of serum proteins 1, 2, 3, 4, 9 and 16 [19] .
Although proteomics overcomes part of the limitations in genomics/transcriptomics and is becoming a promising method to investigate the action mechanisms of TCM [16, 20] , the reconciliation and integration of TCM and modern medicine requires the combination of proteomics with other disciplines such as metabolomics.
Metabolites, as the final products of cellular regulatory processes, represent the ultimate response to the changes induced by genetic and external perturbations [21] . Metabolomics is a discipline dedicated to the systemic study of global metabolite profiles of a biological system (e.g., cells, tissues, organs, or biological fluids), which has become a key part of systems biology [22] . By metabolomic approaches, one can define the metabolic profile changes of the human body (or laboratory animals) induced by TCM, which will undoubtedly provide in-depth understanding of action mechanisms of TCM formulae [23] .
Metabolic profiling is helpful to elucidate the therapeutic mechanisms of TCM. By the combinatorial use of UPLC-ESI-MS and principal components analysis (PCA), Wang et al. measured the metabolic profiles of alcohol-caused hepatotoxicity (a model of alcohol-induced liver disease) and the profile alteration by Yin Chen Hao Tang (YCHT) intervention [24] . YCHT is a classic TCM formula, composed of three herbal drugs: Artemisia capillaris Thunb., Gardenia jasminoides Ellis, and Rheum palmatum L., which has been used for treating jaundice and liver disorders for nearly 2,000 years [24] . To prove the effectiveness of YCHT, urinary samples from control, alcohol-and YCHT-treated rats were collected and analyzed via UPLC-ESI-MS. Three dominant ions (m/z 664.3126 (9.00 min), m/z 155.3547 (10.96 min), m/z 708.2932 (9.01 min)) were observed from alcohol-treated rats compared with the control and YCHT-treated rats, which might be related to the development of alcohol hepatotoxicity. The concentration of m/z 664.3126 (9.00 min) in the alcohol-treated rats was approximately 5-fold higher than that in the control rats and YCHT-treated group, whereas ions with m/z 155.3547 (10.96 min) and m/z 708.2932 (9.01 min) were at a lower concentration compared with those in the control and YCHT-treated rats. Meanwhile, the concentrations of these ions were not statistically different between control and YCHT-treated rats. Besides, the ion at m/z 664.3126 was found to correspond with ceramide, but the other two compounds have not been determined as yet. As suggested by many reports, alcohol can disturb the sphingomyelin signaling pathway in the liver by activation of tumor necrosis factor-α (TNF-α), which results in the increased production of ceramide [25] [26] [27] [28] . This study thus provided solid evidence to support the involvement of the sphingomyelin signaling pathway in alcohol hepatotoxicity and the intervention effects of YCHT as well. Accordingly, these three compounds, especially ceramide, may serve as biomarkers for diagnosis of alcohol hepatotoxicity.
Sini decoction (SND), composed of three medicinal herbs: Rheum palmatum L., Zingiber officinale Roscoe and Aconitum carmichaeli Debeaux, recorded in the Chinese pharmacopoeia 2010 edition, has been used to treat cardiovascular disease for many years [29, 30] . High-performance liquid chromatography coupled with mass spectrometry has been successfully applied to evaluate the metabolomic intervening effect of SND for treating myocardial infarction (MI). Nineteen metabolites involved in glycolysis, the citrate cycle, amino acid metabolism, purine and pyrimidine metabolism were identified as potential biomarkers corresponding to MI. It was revealed that the myocardial ischemia and oxygen deficiency would lead to a high rate of glycolysis, lactate accumulation, inhibition of the citrate cycle and other disturbed metabolism and that SND could restore the unbalanced myocardial energy metabolism [29] .
TCM databases and dissection by bioinformatics
Thanks to the rapid progress in omics study of TCM, rich information about active components and associated targets of TCM herbs and formulae has been accumulated [7] , which provides an unprecedented opportunity to dissect TCM by bioinformatics. In this section, some free TCM databases are first introduced and then an example is given to show the use of bioinformatics in TCM dissection
The Traditional Chinese Medicine Information Database (TCM-ID):
The Traditional Chinese Medicine Information Database (TCM-ID; http://tcm.cz3.nus.edu.sg/group/tcm-id/tcmid.asp) has been mainly developed by the College of Life Sciences, Zhejiang University together with the Department of Pharmacy and the Department of Computational Science, National University of Singapore. This database is a web-based resource to provide information about several aspects of TCM herbs, including formulae, herbal ingredients, therapeutic effects, and clinical indications. TCM-ID covers 1,102 reputable herbs, 9,862 herbal ingredients, 1,588 TCM formulae and 3D structures of 3,725 herbal ingredients [31] .
3.2.
TCM database@Taiwan: TCM Database@Taiwan (http://tcm.cmu.edu.tw/) is one of largest web-based TCM databases, which was established by the School of Chinese Medicine of China Medical University in Taiwan [32] . This database contains 37,170 (32,364 non-duplicate) TCM compounds extracted from 453 different herbs, animals and minerals. This database can be queried through specifying search clauses, such as molecular properties, substructures, TCM ingredients, and TCM classification, based on intended drug actions. All molecules available for download have been geometrically minimized and could be used in docking programs.
Herb Ingredients' Targets (HIT):
Herb Ingredients' Targets (HIT; http://lifecenter.sgst.cn/hit/) is a comprehensive and fully curated database established by the Shanghai Center for Bioinformation Technology, Chinese Academy of Sciences and Tongji University [33] . It currently includes about 1,301 known protein targets (in which 220 proteins are direct targets), and covers about 586 active compounds from more than 1,300 reputable Chinese herbs. This information is very helpful to elucidate the synergistic mechanisms of TCM formulae. and also links to Drugbank, OMIM, and PubChem. Because its web-based software displays a network for integrative relationships between herbs and the diseases that they treat, the active ingredients and their targets, TCMID will facilitate the study of combination therapy and understanding of the underlying mechanisms for TCM at the molecular level, which bridges the gap between TCM and modern medicine.
Dissecting TCM by bioinformatics. A case study on
Salvia miltiorrhiza Bunge: The combination of these TCM databases and other biological databases can help us to understand the molecular mechanisms of TCM therapy. The power of this strategy is preliminarily shown in a case study on a famous TCM herb S. miltiorrhiza, which has been widely used for hundreds of years in China. In recent years, research on the chemical composition, pharmacological activity, and clinical application of S. miltiorrhiza has made great progress. It can treat numerous ailments including cardiovascular diseases [35] , mental and nervous conditions [36] , and has immuno-modulatory effects in cancer patients [37] .
To obtain deeper insights into the pharmacological mechanisms of S. miltiorrhiza, we collected 124 components of the herb from TCMID, which are associated with 361 targets considering the close links between therapeutic effects of drug targets and their potential in causing genetic diseases [38, 39] , The Database for Annotation, Visualization, and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov/) [40] was searched and 149 targets were found to be genetic disease genes, in which 125 targets are linked to cardiovascular, cancer, neurological, and immune diseases, which are closely related to the medicinal effects of S. miltiorrhiza. A further analysis of these targets was performed by searching Therapeutic Target Database (TTD; http://bidd.nus.edu.sg/group/cjttd/) [41] . It was found that in the 125 targets, 23 are hit by approved drugs, 17 by clinical drugs, and 33 by in-research drugs. As shown in Table 2 , 17 of 23 successful targets and 14 of 17 clinical targets are associated with the treatment of cardiovascular diseases, cancer, neurological disorders, and immune diseases, which are just the recognized therapeutic Dissecting Traditional Chinese Medicines by omics and bioinformatics Natural Product Communications Vol. 9 (9) 2014 1395 effects of S. miltiorrhiza. More interestingly, most of the agents hitting these targets, such as tanshinone ii (a, b), tanshinone i, cryptotanshinone, salvianolic acid (a, b), and dihydrotanshinone i, are indeed active ingredients of S. miltiorrhiza (Table 2) [42, 43] . Therefore, it is reasonable to infer that these targets are tightly coupled with the pharmacological effects of S. miltiorrhiza and thus are of special interest in future target-based drug development.
